文献速递乳腺癌

体重指数与年龄和绝经前乳腺癌风险的关联

Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women.
PubMed 文献 · JAMA Oncol · 2018-11-08

该多中心汇总分析纳入758 592名绝经前女性,随访中位9.3年,发生13 082例乳腺癌。结果显示BMI与绝经前乳腺癌风险呈负线性关联,18-24岁BMI关联最强(每5 kg/m² HR 0.77),且雌激素受体阳性/孕激素受体阳性肿瘤关联更强。

要点

  • 绝经前女性BMI越高,乳腺癌风险越低,18-24岁BMI关联最强。
  • BMI最高与最低类别间风险梯度达4.2倍(HR 0.24)。
  • 激素受体阳性肿瘤的负关联强于激素受体阴性肿瘤。

核心结论

  • 增加脂肪量与绝经前乳腺癌风险降低相关,关联强度大于既往所示,且贯穿整个BMI分布。

研究设计与样本

  • 多中心汇总分析,纳入19个前瞻性队列的758 592名绝经前女性,中位随访9.3年,发生13 082例乳腺癌。

主要发现

  • 18-24岁BMI每增加5 kg/m²,绝经前乳腺癌风险HR为0.77(95% CI 0.73-0.80)。
  • 45-54岁BMI每增加5 kg/m²,HR为0.88(95% CI 0.86-0.91)。
  • 18-24岁BMI最高(≥35.0)与最低(<17.0)类别间风险梯度4.2倍(HR 0.24,95% CI 0.14-0.40)。
  • 18-24岁BMI每增加5 kg/m²,雌激素受体阳性/孕激素受体阳性肿瘤HR 0.76(95% CI 0.70-0.81),激素受体阴性肿瘤HR 0.85(95% CI 0.76-0.95)。

临床怎么用

  • 临床评估绝经前乳腺癌风险时,应关注年轻成年期BMI,而非仅当前BMI。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The association between increasing body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) and risk of breast cancer is unique in cancer epidemiology in that a crossover effect exists, with risk reduction before and risk increase after menopause. The inverse association with premenopausal breast cancer risk is poorly characterized but might be important in the understanding of breast cancer causation. OBJECTIVE: To investigate the association of BMI with premenopausal breast cancer risk, in particular by age at BMI, attained age, risk factors for breast cancer, and tumor characteristics. DESIGN, SETTING, AND PARTICIPANTS: This multicenter analysis used pooled individual-level data from 758 592 premenopausal women from 19 prospective cohorts to estimate hazard ratios (HRs) of premenopausal breast cancer in association with BMI from ages 18 through 54 years using Cox proportional hazards regression analysis. Median follow-up was 9.3 years (interquartile range, 4.9-13.5 years) per participant, with 13 082 incident cases of breast cancer. Participants were recruited from January 1, 1963, through December 31, 2013, and data were analyzed from September 1, 2013, through December 31, 2017. EXPOSURES: Body mass index at ages 18 to 24, 25 to 34, 35 to 44, and 45 to 54 years. MAIN OUTCOMES AND MEASURES: Invasive or in situ premenopausal breast cancer. RESULTS: Among the 758 592 premenopausal women (median age, 40.6 years; interquartile range, 35.2-45.5 years) included in the analysis, inverse linear associations of BMI with breast cancer risk were found that were stronger for BMI at ages 18 to 24 years (HR per 5 kg/m2 [5.0-U] difference, 0.77; 95% CI, 0.73-0.80) than for BMI at ages 45 to 54 years (HR per 5.0-U difference, 0.88; 95% CI, 0.86-0.91). The inverse associations were observed even among nonoverweight women. There was a 4.2-fold risk gradient between the highest and lowest BMI categories (BMI≥35.0 vs <17.0) at ages 18 to 24 years (HR, 0.24; 95% CI, 0.14-0.40). Hazard ratios did not appreciably vary by attained age or between strata of other breast cancer risk factors. Associations were stronger for estrogen receptor-positive and/or progesterone receptor-positive than for hormone receptor-negative breast cancer for BMI at every age group (eg, for BMI at age 18 to 24 years: HR per 5.0-U difference for estrogen receptor-positive and progesterone receptor-positive tumors, 0.76 [95% CI, 0.70-0.81] vs hormone receptor-negative tumors, 0.85 [95% CI: 0.76-0.95]); BMI at ages 25 to 54 years was not consistently associated with triple-negative or hormone receptor-negative breast cancer overall. CONCLUSIONS AND RELEVANCE: The results of this study suggest that increased adiposity is associated with a reduced risk of premenopausal breast cancer at a greater magnitude than previously shown and across the entire distribution of BMI. The strongest associations of risk were observed for BMI in early adulthood. Understanding the biological mechanisms underlying these associations could have important preventive potential.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Schoemaker MJ, Nichols HB, Wright LB, et al. Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women. JAMA Oncol. 2018. PMID: 29931120. doi:10.1001/jamaoncol.2018.1771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。